Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?

L A Mekuria; JM Prins; A W Yalew; MAG Sprangers; PT Nieuwkerk

doi:10.1111/tmi.12709

Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?

L A Mekuria, JM Prins, A W Yalew, MAG Sprangers, PT Nieuwkerk

Epidemiology

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	856-869
Number of pages	14
Journal	Tropical Medicine and International Health
Volume	21
Issue number	7
DOIs	https://doi.org/10.1111/tmi.12709
Publication status	Published - 2016

Research programs

EMC NIHES-01-64-01

Access to Document

10.1111/tmi.12709

Cite this

Mekuria, L. A., Prins, JM., Yalew, A. W., Sprangers, MAG., & Nieuwkerk, PT. (2016). Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring? Tropical Medicine and International Health, 21(7), 856-869. https://doi.org/10.1111/tmi.12709

@article{44e9540358f84ffa8ec267031de62f47,

title = "Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?",

author = "Mekuria, {L A} and JM Prins and Yalew, {A W} and MAG Sprangers and PT Nieuwkerk",

year = "2016",

doi = "10.1111/tmi.12709",

language = "Undefined/Unknown",

volume = "21",

pages = "856--869",

journal = "Tropical Medicine and International Health",

issn = "1360-2276",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "7",

}